🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

While we had a great #ASCOGI25, I will say this again: It is a failure of mentorship when full professors are standing on the podium presenting new data. Time to make way for the next generation folks.

Please join us for the next AHPBA clinical trial webinar discussing endpoints! Great speakers lined up! Michael Cavnar Alexandra Gangi, MD Julie Hallet Syed A. Ahmad Flavio G Rocha, MD, FACS, FSSO Bas Groot Koerkamp Michael Lidsky, MD, FACS Motaz Qadan, MD, PhD Jason W Denbo Sean Cleary Shimul A. Shah AKHIL CHAWLA Timothy M. Pawlik

📢 Looking to share your expertise? Be noticed for HPB events? 🤩 Join the IHPBA Faculty Directory and help build a representative inclusive speaker registry for HPB surgery ⭐️For *all* IHPBA members in practice⭐️ Join 🌍🔗form.jotform.com/242872408317055

Please join us tomorrow for a great education webinar on endpoints in clinical trials. Spread the word to all trainees! Bas Groot Koerkamp Hop S. Tran Cao Zhi Ven Fong, MD MPH DrPH Yuman Fong Lee M. Ocuin MD, FACS Syed A. Ahmad Sean Cleary Shimul A. Shah Flavio G Rocha, MD, FACS, FSSO Roberto Hernandez-A Julie Hallet

Standing room only for debate on #NAT for resectable pancreas cancer featuring RCT PIs AHPBA #AHPBA2025 PanCAN OHSU Knight Cancer Institute @OHSUpancreatic Knut Jørgen Labori NORPACT-1 🇳🇴 Bas Groot Koerkamp PREOPANC-2 🇳🇱 Have we reached consensus on a SOC? Wait for Alliance for Clinical Trials in Oncology 021806/PREOPANC-3?

Thankful for the opportunity to present late breaking #clinicaltrials in #pancreas AHPBA amongst a wonderful team of HPB surgeons (and for my Rutgers Cancer Institute support in the crowd!)

Looking forward to it and honored to be invited! Dr. Cathy Eng Yelena Y. Janjigian MD

So honored to have Dr. Nancy Kemeny give the Blumgart Historical Lecture at #AHPBA2025 Inspiring to see the history and evolution of #HAI⛽️ tx for mCRC and #cholangiocarcinoma Amazed to see just a sample of the sheer # of Surg fellows trained in this life-saving 🎁 to pts.

Great Debates There’s no Debating a Huge Shoutout to the Course Directors Dr. Cathy Eng Yelena Y. Janjigian MD , “Mufasa” him self Vivek Subbiah, MD , every The Med Oncs “ Surg Onc” Sepideh Gholami, MD, MAS, FACS, FSSO and amazing faculty Namrata (Neena) Vijayvergia MD for keeping us thinking “ Is there another way”

Discovery in management of #CRLM - how far can we go? Expert panel at #SSO2025 to review implication of recent trials - COLLISION, TRANSMET, ORCHESTRA with Åsmund A. Fretland Michael D’Angelica Sepideh Gholami, MD, MAS, FACS, FSSO Sajid Khan Sandra DiBrito Colin Court Susanne Warner Take-aways👇🏻

Åsmund A. Fretland Michael D’Angelica Michael Lidsky, MD, FACS Finally: use of biomarkers for patient selection with Sepideh Gholami, MD, MAS, FACS, FSSO Know biomarkers - it’s #surgonc responsibility to be able to have those discussions with oncology colleagues Think KRAS, BRAF, MSI, sidedness & ctDNA /4

Excited to bring this new technology to our patients with liver tumors in Long Island and greater NYC. More tools in the toolbox. Matt Weiss Joseph Michael Herman Nicholas Hornstein Gerardo Vitiello Danielle DePeralta Richard Barakat Northwell General Surgery Residency Northwell Health Martin S Karpeh, Jr., MD

Sepideh Gholami, MD, MAS, FACS, FSSO with a master class on the role of HAIP for patients with liver-confined mCRC and the need for modern prospective data for this patient group with the EA2222 PUMP trial led by Michael Lidsky, MD, FACS ASCO COLONTOWN Fight Colorectal Cancer ECOG-ACRIN Cancer Research Group

Fantastic session by Sepideh Gholami, MD, MAS, FACS, FSSO and colleagues on liver directed therapy for CRLM: from SBRT to liver transplant! 5 year 60% OS with transplant in US 👍 #ASCO2025

What a great study!!!

Thank you ASCO for the invitation to lead this educational session and my co-speakers for an engaging discussion on Liver-directed therapies for patients with colorectal liver metastases. Colorectal Cancer Provider Outreach Program 💙 COLONTOWN Fight Colorectal Cancer

If this were a pill, we’d call it revolutionary. It would headline plenaries, get FDA priority review, and cost $10,000 a month. Instead—it’s structured exercise. 🆕 NEJM June 2025 | CHALLENGE Trial Stage II–III colon cancer patients post-chemo (n=889) 📦 RCT of 3 years of

Indeed, blown away by Miriam Merad, MD, PhD! What a fascinating story about the myeloid lineage of macrophages. Cold Spring Harbor Laboratory Northwell Health

A fantastic choice! Congrats my friend Alexandra Gangi, MD! Can’t wait to see the growth of the division under your leadership!

Excited to share our new publication on liver-directed therapies for colorectal liver metastases. Thank you to my co-authors & ASCO for the opportunity to run this educational session! Nicholas Hornstein Northwell Health COLONTOWN Colorectal Cancer Alliance ascopubs.org/doi/10.1200/ED…